Skip to main content
Premium Trial:

Request an Annual Quote

Devgen in RNAi Collaboration with Genentech

NEW YORK, June 2 - Devgen has completed a research collaboration with Genentech using RNAi in C. elegans to elucidate the role of genes in cellular pathways related to cancer, the company said today.

 

Devgen, of Ghent, Belgium, has created a genome-wide library of RNA interference sequence to suppress the activity of of the 19,000 C. elegans genes. Devgen plans to use the library in drug-target identification and functional validation. It uses the RNAi along with its Function Factory, a database that includes the phenotypic profiles of C. elegans mutants as well as the effect of gene knockdowns, drugs, and other compounds on the mutants.

 

The parties did not disclose the financial terms of the agreement.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.